INTRODUCTION
Human hemoglobins differ with respect to their concentrations within the red cell. Hemoglobin A2 (ai28), a normal component, is found at a concentration only 1/40 that of Hb A (a2f2). A low rate of synthesis of the 8-chain, relative to the 8-chain, is considered to be responsible for that proportion, and several possible mechanisms have been suggested (1) (2) (3) . Most abnormal hemoglobins vary from the normal in single amino acid substitutions; the proportions in which they are found in hemolysates vary widely. Hemoglobin JBangkok and JBaltimore comprise more than 50% of the hemoglobin in hemolysates of heterozygotes (4) (5) (6) (7) ; hemoglobins GAecra and Klbadan comprise about 50% (8, 9) , whereas hemoglobins Nicosia (10), Joxford (11) , Caserta (12) , Koln (13) , Torino (14) , and Ube 1 (15) comprise 20% or less.
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These differences are not only thought to reflect variations in rates of protein synthesis, but variations in rates of destruction of the abnormal proteins. In the first case, change of a base in a codon not only may cause substitution of one amino acid by another, but it may also alter the level of the mutant protein being produced. The mutant codon may alter the stability of RNA (16) , or it may have maximum affinity for a transfer RNA that is in short supply (17) . Anomalous folding of messenger RNA, produced by the new codon, may alter topographic relations between it and ribosomes in such a manner that initiation or continuation of protein synthesis may be affected (4) . Steric properties of the incomplete polypeptide chain, altered by the new amino acid, may facilitate or inhibit further synthesis (1, 4) . The mutant polypeptide chain may have decreased affinity for another subunit of the molecule, and completion of synthesis may require binding of that subunit (18, 19) .
On the other hand, observed differences in the concentration of abnormal hemoglobins may reflect properties of gene products rather than altered rates of synthesis.
In a heterozygote, red cells may vary in their content of abnormal hemoglobin. If cells with more of that hemoglobin are preferentially destroyed, hemolysates prepared from cells that have survived the selection process will contain less of the abnormal protein than was actually synthesized (20) (21) (22) . Gabuzda, Nathan, and Gardner (23) , Reider, Zinkham, and Holtzman (24) , and Rigas and Koler (25) have extended this concept to include unstable hemoglobins, which may denature and be removed from red cells before the cell is destroyed. De- naturation of hemoglobin, or its removal from the red cell, shortens cell survival: the unstable hemoglobins characteristically occur in relatively low concentration, and they may produce hemolytic anemia.
Actually, alterations of hemoglobin synthesis and destruction probably operate in concert to produce ob-served concentrations of abnormal hemoglobins. In the present study, members of a family of Ashkenazy Jews were found to be carriers of hemoglobin Hasharon, an abnormal hemoglobin first described in a Jewish family in Israel (26) . Hemolysates contained only 16-19% METHODS Hematologic data, including measurement of red cell survival with tmCr, were obtained by standard laboratory methods; electrophoresis wa-s performed as described in earlier publications from this laboratory (27) . Chromatography of hemoglobin on DEAE-Sephadex was performed according to Huisman and Dozy (28) ; chromatography of globin on carboxymethyl-cellulose was performed by the procedure of Clegg, Naughton, and Weatherall, with the exception -that the end buffer was 0.05 M phosphate (29) . Analyses of isolated globin chains were carried out by Doctors Oestertag and Smith; a detailed description of their studies has been submitted for publication.' Haptoglobin in plasma was measured by an immunoassay, using commercial antiserum to human haptoglobin.2 The effect of oxidant agents upon Hb
Hasharon was determined by incubation of red cells with 5 volumes of 1% brilliant cresyl blue, 0.002 M primaquine diphosphate, or 0.01 M acetylphenylhydrazine for 3 or 24 hr at 370C. Autohemolysis after sterile incubation at 370C for 48 hr was measured by the method of Young, Izzo, Altman, and Swisher (30) . Old and young red cells were separated by ultracentrifugation (31) , or by the use of phthalate esters (32) .
Denaturation by heat. Hemolysates from A-S and AHasharon heterozygotes were diluted to approximately 2.0 g/100 ml with 0.1 si PO buffer, pH 7.4, and heated at 550, 600, or 65°C for 15, 30, or 60 min. Samples were centrifuged, supernatants were decanted, and their content of undenatured hemoglobin was measured as cyanmethemoglobin. Starch block electrophoresis was carried out on portions of the supernatants, and the proportion of each hemoglobin component that had been denatured was calculated from the difference between its concentration in the sample and that in an unheated control.
Hemoglobins A, S, C, and Hasharon were isolated from the blood of heterozygotes, and these fractions were concentrated by ultrafiltration and dialysis against 0.1 M P04, pH 7.4, to a concentration of about 2.8 g/100 ml. Aliquots of the fractions were heated at 550, 600, or 650C for 15, 30, or 60 min, centrifuged, and the concentration of hemoglobin in the supernatant was measured as cyanmethemoglobin.
Alkali deniaturation. Hemoglobins A, S, C, and Hasharon were separated from hemolysates of heterozygotes by starch block electrophoresis, and concentrated to 0.5-1.5 g/100 ml by ultrafiltration. After overnight dialysis at 40C against 0.001 M P04 buffer, pH 7.4, ilkali denaturation was measured by the method of Huisman and Meyering (33) and by the method of Singer, Chernoff, and Singer (34 Incorporation of 'Fe into hemoglobins A and Hasharon in vivo. At the time that their red cells were labeled with 5aCr, the propositus and a nephew also received intravenous doses of 5 ,uc of citrateJwFe. Blood samples were collected at intervals, and hemoglobins A and Hasharon were separated by starch block electrophoresis. Fractions were concentrated by ultrafiltration, and their specific activity (cpm/ODuo) was determined.
Hemoglobin synthesis in vitro. Bone marrow was aspirated into a large volume of heparinized cold NKM solution (35) . No attempt was made to "enrich" reticulocytes in experiments with venous blood. Studies were performed according to Lingrel and Boorsook (36) with the following modifications: heparinized blood or bone marrow was washed three times with cold NKM solution, and then preincubated in capped vials for 10 min at 35°C. Dialyzed plasma was omitted from the reaction mixture. Total sample volume was 0.7 or 0.8 ml. After preincubation, equal amounts of labeled amino acid were added to each vial, and vials were removed from the shaking incubator at desired time periods. Incubation was stopped by addition of 2 ml of 0.01 M Tris-HC1 (pH 7.5, containing 0.001 M KCN), and freezing in a dry ice-acetone bath; samples were stored at -25°C.
Later Carboxymethylcellulose chromatography of globin prepared from the blood of the propositus revealed, in addition to normal components, a peak that was eluted more slowly than normal alpha chains (Fig. 3) . Analysis of this peak1 indicated that aspartic acid in position 47 of the alpha chain had been replaced by histidine, a substitution identical to that described for hemoglobin Hasharon (26) . Partial ionization of histidine (pK12 6.1) can account for the apparent difference of 1 1 charge units between Hb A and Hb Hasharon at pH 7.0.
Effect of oxidants on Hb Hasharon. Equal numbers of inclusions were produced in red cells from the propositus and from a normal control after incubation with brilliant cresyl blue. Similar results were obtained after tated from an A-S hemolysate under the same conditions, but to a lesser degree than did Hb Hasharon.
When purified solutions of hemoglobins A, S, C, and
Hasharon were heated, Hb Hasharon was more readily precipitated than the other three hemoglobins tested (Fig. 4 ). Conversion to cyanmethemoglobin before heating prevented heat precipitation of all hemoglobins tested. Alkali denaturation. Purified Hb Hasharon was somewhat more resistant to denaturation by alkali than Hb A eluted from the same starch block, or the same column of DEAE-Sephadex, using either of two techniques (Table II) . Alkali-resistance of all samples studied was higher than anticipated, particularly if they had normal fractions were equal in all studies (Fig. 6) . Similar experiments, using marrow from hematologically normal persons with either Hb S or Hb C trait, yielded the same result. Incorporation of labeled amino acids into hemoglobin was studied with reticulocytes from II-10, III-9, and III-11. In contrast to results of the incubation of bone marrow, specific activity of Hb A was higher than that of Hb Hasharon (Fig. 6 ). Studies carried out with reticulocytes from hematologically normal individuals with sickle-cell trait (Fig. 6) , or Hb C trait, also showed the specific activity of Hb A to be greater than that of the abnormal hemoglobin. Separation of old and young red cells. Old and young red cells were separated from the blood of two heterozygotes by ultracentrifugation. Reticulocyte counts in the "young" fraction were from two to three times that of whole blood, whereas reticulocytes in the "old" fraction were decreased by 20-80%. The proportion of Hb Hasharon in old and young cells did not differ significantly. Similar studies, using the phthalate ester technique, were carried out with blood from III-9, and carriers of Hb S, C, and Zurich (Table III) (26) . The hemoglobin was initially described in an Israeli family, and has also been detected in Texas (37) . In both of those reports the fetal analogue of Hb Hasharon (a2'7 hisy2) was detected in a survey of umbilical cord bloods. Affected parents in both instances were Ashkenazy Jews. The family from Texas initially came from Galicia' and could conceivably have had an ancestor in common with the family from Baltimore.
Red cell survival was normal in one member of the Texan kindred,3 but survival was shortened in III-13 and at the lower limit of normal in III-11. Low proportions of abnormal hemoglobin were present in the 'Alperin, J. B., and R. G. (49, 50) , and young reticulocytes produced in response to hemorrhage cannot be compared with more mature forms from nonanemic donors (16) . The studies of Heywood, Karon, and Weissman, and of Boyer, Hathaway and Garrick can be compared with the data reported here (51, 16) . Specific activities of hemoglobins A and S were found to be equal in the former study, while Boyer and coworkers found a higher specific activity in the normal component. That finding was attributed to instability of the abnormal messenger RNA, for a progressive decrease in Hb S synthesis was observed when marrow cells, young reticulocytes, and old reticulocytes were compared (16) .
When in vitro synthesis by bone marrow of heterozygous carriers was investigated, the specific activity of Hb S C, or Hasharon was equal to that of Hb A, even after very brief periods of time (Fig. 6 ). Few studies of hemoglobin synthesis by marrow cells are available for comparison, but studies carried out in vivo might be expected to yield similar data. Ranney and Kono found the specific activity of normal and abnormal hemoglobins to be equal, after administration of 'Fe to persons with Hb S or Hb C trait (52) . In contrast, Levere and Lichtman found unequal specific activities of hemoglobins A and S in persons with sickle-cell trait. They suggested that the two hemoglobins might be "turned over" at different rates, due to heterogeneous distribution between cells (53) . A similar explanation has been suggested for the unequal specific activities of Hb S and F found in patients with sickle-cell anemia (20-22, 54, 55). The anticipated effects of a heterogeneous distribution are outlined in the Appendix.
Our in vitro experiments suggest that the proportion of isotope incorporated into Hb Hasharon was the same as the proportion of that hemoglobin in the nonsynthesizing red cells which contaminated the marrow aspirate, about 18%, rather than the 20-27% of "9Fe incorporated in vivo. Discrepancy between the in vivo and in vitro studies could be explained if some newly synthesized Hasharon globin or hemoglobin precipitated in the latter experiments during the preparation of hemolysates for chromatography, despite precautions taken to avoid de--naturation. It is unlikely that denaturation of hemoglobin occurred during the incubation per se, for specific activities of Hb A and Hasharon were equal after even very brief periods of incubation (Fig. 6) . Exchange of hemes (56) or globin chains,4 may have introduced uncontrolled artefacts in one or in both studies. The difference between the studies is small, however, and it seems most likely that both in vivo denaturation and decreased synthesis are responsible for the low proportion of abnormal hemoglobin in hemolysates, with the latter mechanism predominant.
It should be noted that, if an appreciable proportion of newly formed aHaiharon chains precipitated before their incorporation into hemoglobin, they would not be detected in our experiments. Synthesis of the abnormal globin could then be considered "ineffective," rather than decreased. If 50% of the nascent chains precipitated, synthesis of aHaaharon, subunits would be equal to that of many other abnormal hemoglobins. Excess 8-chains would not be likely to accumulate, if preformed a-chains are a prerequisite for their release from ribosomes (19) . It is expected that normoblasts in the bone marrow would contain inclusions composed of the precipitated chains; in our studies, appropriate stains were not utilized to rule out that possibility. We would expect red cell morphology to be abnormal (38, 61, 62) ; it was not.
The normal appearance of erythrocytes, the relatively poor yield of reticulocytes in flotation experiments, and the mildness of hemolytic anemia in carriers are consistent with a relatively small amount of denaturation of Hb Hasharon in circulating red cells. As outlined in the Appendix, mean red cell life span is inversely related to the proportion of an unstable hemoglobin synthesized, and it may be of some evolutionary advantage for an unstable hemoglobin to be synthesized in smaller amounts than are the more stable proteins. A similar suggestion has been advanced by Beretta, Prato, Gallo, and Lehmann, in discussing the very low proportion of Hb Torino (14) .
Abnormal hemoglobins involving mutations at the a-47 locus have been described in widely divergent ethnic groups; all of these hemoglobins appear to have certain properties in common. In hemoglobins Kokura, Umi, and LFerrara, residue a-47 is glycine rather than the histidine found in Hb Hasharon (57, 58) . The former hemoglobins are also found in low proportion, and carriers have mild reticulocytosis (Table IV) . Hemoglobin Columbia also has the formula an47 g8yp82, and it displays heat precipitability very similar to that observed with Hb Hasharon.' The molecular alterations involved in heat precipitation are unclear, but they may involve dissociation of the hemoglobin molecule, with precipitation of relatively unstable free globin chains (64) . The process is quite sensitive to changes in pH, and cyanmethemoglobin derivatives are very much more resistant to denaturation than are oxyhemoglobins. Residue a-47, which corresponds to position CD5 in the Perutz model of 'Nagel, R. L. Personal communication. Hemoglobin % Sahli.
hemoglobin (59), is on the external surface of the molecule,6 and it would be expected to have interactions with other hemoglobin molecules, as well as with solvent molecules. No convincing theory relating the charge difference of Hb Hasharon at that position to the properties of the molecule can be advanced at present. Hemoglobins Hammersmith and Torino, which are quite heat-labile, involve mutations at position CD1; this is an important point of heme contact, and the mechanisms producing instability are probably quite different from that which exists in Hb Hasharon (60) . The data presented here are compatible with the hypothesis that the low proportion of Hb Hasharon in hemolysates is produced by a combination of decreased synthesis and increased destruction. Synthesis is not as low as that of Hb A2, and destruction is not as rapid as that seen with more unstable hemoglobins. It is probable that, if Hb Hasharon were synthesized in greater amounts, the red cell lesions produced by the increased amount of denatured hemoglobin might shorten red cell survival even further, and would produce overt hemolytic anemia.
red cell once it has appeared in peripheral blood. Denaturation of X may be assumed to be continuous in each cell, proceeding at a rate proportional to the amount of nondenatured X in the cell. Furthermore, it is assumed that:
(a) A radioactive "pulse" label incorporated into normal and abnormal hemoglobins is neither exchanged between molecules during the cell's life nor reincorporated after destruction of the original cohort.
(b) Denatured abnormal hemoglobin is either removed from the cell or is altered in such a way that it does not appear in hemolysates. Coprecipitation of the normal hemoglobin is negligible during the life of the cell.
(c) Red cells are destroyed as soon as a "lethal" amount of X has denatured. Destruction may be due to altered physical properties of the cell, functional lesions of its membrane, or some combination of these factors (38, 61, 62) . Applications of the model to studies of hemoglobin synthesis proceed immediately from a formal statement. If a labeled cohort appears in the peripheral blood at t = 0, then at any time t, the amount of remaining abnormal hemoglobin in a cell that initially contained X in the proportion a, is X(t) = hae-t/, [1] where r is the time constant of denaturation and h is the total initial amount (in egg) of hemoglobin in a cell. (h is assumed to be a constant.) The cell described by equation 1 obviously contained initially an amount ha of the component X, and it will be destroyed at that time t at which the amount of denatured X has reached a "lethal" level k:
In order to express the fact that a in equation 2 a is no longer an independent variable we restate this relation as follows: at any time t those cells are being destroyed which initially con- =k h(1 -e-t/,) [3] Hence, the total number N(t) of labeled cells circulating is Nastk k/h(l-e-//r) N(t) = No f(a)da J f(ar)da [4] APPENDIX The two types of hemoglobin contained in the red cells of any heterozygote are called X, the abnormal hemoglobin, and Y, the normal hemoglobin. Generally, they are synthesized at different rates. If the fraction of X in the newly formed cell is a, the ratio of X to Y is a(l -a). Initially, a may vary from cell to cell according to f(a.), to which the usual properties of a probability density function are assigned. For simplicity, we can let the distribution be Gaussian, centered at & and with a variance of o2. If the cells of a heterozygote show "uniform distribution" of X, a becomes zero (i.e., a = & for all cells). If X is an unstable hemoglobin, the life span of the cells under discussion generally is shortened. During their life span, X becomes denatured. Denaturation can be approximated by an exponential function, defined for the entire life span of a 6 Perutz, M. F. Personal communication.
where No is the original number of cells in the cohort, and the total amount of X in the labeled cohort becomes [X(t)]tot = he-t/r f af(a)da [5] The total radioactivity of X at any time is proportional to equation 5. Detailed descriptions of the time course of specific activity can be obtained most easily by studying cells containing initially equal amounts (ha) of X (or cells for which f(a) has a very small a). Then we have in each and every cell: X(t) = hae-t0 [9] such that the average amount of abnormal hemoglobin in all cells is -h rT X = Ma f e-t/dt [10] where T is the life span of these cells given by The value of k could be predicted from equation 13 initial and final specific activity were known. The ratio of these two measurements depends directly on the initial concentration (a) of X in the cell, and on k:
SA (t T ) =1--(where e = a short time) [14] Data of this type are not available for Hb Hasharon, and k cannot be estimated from equation 14.
In theory (Fig. 7 A) , the time constant of denaturation (Tr) may be quite long, whereas the life span of the red cell may be significantly less than 120 days. If small amounts of denatured X can lead to cell destruction, the critical level k is reached long before the initial concentration of X has decreased significantly. (This fact also causes the decay curve to appear almost linear.) Specific activity of X may appear to be "unexpectedly" large during the 1st 30-50 days, especially if the life span of the cells is close to 120 days. Curve 2 of Fig. 7 A represents such a case, in which a = 30%, k = 12% were assumed.
Conflicting evidence has been presented regarding the distribution of abnormal hemoglobins between cells (53, 63) . Data for fetal hemoglobin are most satisfactory: it is nonuniformly distributed in thalassemia and sickle-cell anemia, but distribution is uniform in hereditary persistence of fetal hemoglobin (20, 21, 54, 55) . Some of the considerations given above for an infinitely narrow f(a) take on a more complex nature if the unstable hemoglobin is distributed more broadly over all cells (a, 5 0). The phenomena encountered, in addition to those above, are illustrated in Fig. 7 B. Those cells that contain the most X(a > a) are destroyed before the majority, so that radioactivity begins to deviate from the exponential decay curve at times considerably less than the average life P.
Two of the introduced quantities determine how soon that deviation may occur: the spread of the distribution curve (o), and the lethal level k. If a is large, an early deviation of specific activity from exponential decay would be easily detectable. If a is not large, its experimental determination during a short period of observation would be difficult if data were scattered. In the case of Hb Hasharon, observation over a period of at least 100 days would be necessary to estimate the distribution of the abnormal hemoglobin. Such a study could not be performed, which was doubly unfortunate, for it might have resolved differences between the in vivo studies that were carried out and the in vitro bone marrow studies.
